Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERF2IP | Q9NYB0 | 5/20 | 0.45 |
| ▸ | BECN1 | Q14457 | 3/20 | 0.45 |
| ▸ | MLLT3 | P42568 | 1/20 | 0.44 |
| ▸ | NPY1R | P25929 | 1/20 | 0.44 |
| ▸ | NPY2R | P49146 | 1/20 | 0.44 |
| ▸ | NPY4R | P50391 | 1/20 | 0.44 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.44 |
| ▸ | F12 | P00748 | 2/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.43 |
| ▸ | TERF2 | Q15554 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | KRAS | P01116 | 1/20 | 0.42 |
| ▸ | F11 | P03951 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14028880 | 0.96 | TERF2IP (0.46) | TERF2IPBECN1MLLT3NPY1RNPY2R | |
| SCHEMBL14028877 | 0.95 | BECN1 (0.44) | TERF2IPBECN1MLLT3NPY1RNPY2R | |
| SCHEMBL16480282 | 0.93 | TERF2IP (0.50) | TERF2IPBECN1MLLT3NPY1RNPY2R | |
| SCHEMBL16480284 | 0.88 | TERF2IP (0.49) | TERF2IPBECN1MLLT3NPY1RNPY2R | |
| SCHEMBL16480283 | 0.81 | SIRT2 (0.45) | TERF2IPNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL10138953 | 0.80 | NPY1R (0.41) | TERF2IPBECN1MLLT3NPY1RNPY2R | |
| SCHEMBL10138947 | 0.73 | NPY1R (0.39) | TERF2IPBECN1MLLT3NPY1RNPY2R | |
| SCHEMBL23351287 | 0.71 | NPY1R (0.53) | BECN1NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL10138943 | 0.70 | SIRT2 (0.42) | NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL19473798 | 0.70 | MC4R (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080242598-A1 | Alpha Helical Mimics, Their Uses and Methods For Their Production | THE UNIVERSITY OF QUEENSLAND (AU) | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242598-A1 | Alpha Helical Mimics, Their Uses and Methods For Their Production | PTMA, VIP, SCTR | TERF2IP 2863/4885BECN1 1696/4885MLLT3 2263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.